R Squared’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

R Squared’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$54	–	1253
2024 Q4	$54	Buy	+2	New	+$56	﹤0.01%	1570

Other funds holding RVPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

R Squared's RVPH Position: Q1 2025 in Review

R Squared sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2025, closing a stake of 2 shares — an estimated $54 sold.

R Squared first reported a position in RVPH in Q4 2024 and held it in 1 quarter. The position peaked at $54 in Q4 2024. 48 funds tracked by Wall St. Rank hold RVPH as of Q1 2025.

R Squared reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2025 after selling out during the quarter.
R Squared sold 2 REVIVA PHARMA HLDGS INC shares in Q1 2025, an estimated $54.
R Squared first reported a position in REVIVA PHARMA HLDGS INC in Q4 2024 and held it in 1 quarter.
R Squared's REVIVA PHARMA HLDGS INC position peaked at $54 in Q4 2024.
48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.